Literature DB >> 7608701

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

K A Jellinger, C Bancher, J J Hauw, M Verny.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7608701      PMCID： PMC1073623          DOI： 10.1136/jnnp.59.1.106

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Authors:  S J Collins; J E Ahlskog; J E Parisi; D M Maraganore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

Review 2.  Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Authors:  J J Hauw; S E Daniel; D Dickson; D S Horoupian; K Jellinger; P L Lantos; A McKee; M Tabaton; I Litvan
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

3.  Progressive supranuclear palsy: neuropathologic and clinical heterogeneity.

Authors:  M Gearing; D A Olson; R L Watts; S S Mirra
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910
  3 in total
  4 in total

1.  Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy.

Authors:  A Padovani; B Borroni; S M Brambati; C Agosti; M Broli; R Alonso; P Scifo; G Bellelli; A Alberici; R Gasparotti; D Perani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

2.  Imaging correlates of depression in progressive supranuclear palsy.

Authors:  Daniele Urso; Benedetta Tafuri; Roberto De Blasi; Salvatore Nigro; Giancarlo Logroscino
Journal:  J Neurol       Date:  2022-01-08       Impact factor: 4.849

3.  Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.

Authors:  C Brenneis; K Seppi; M Schocke; T Benke; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

Review 4.  Biological fluid biomarkers in neurodegenerative parkinsonism.

Authors:  Michael Eller; David R Williams
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.